Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 7, 2011; 17(25): 3043-3048
Published online Jul 7, 2011. doi: 10.3748/wjg.v17.i25.3043
Figure 1
Figure 1 Pooled analysis of p16 hypermethylation in tumorous liver tissues and non-tumorous liver tissues of hepatocellular carcinoma patients. HCC: Hepatocellular carcinoma.
Figure 2
Figure 2 Pooled analysis of p16 hypermethylation in tumorous liver tissues of hepatocellular carcinoma patients and healthy liver tissues of patients with other diseases. HCC: Hepatocellular carcinoma.
Figure 3
Figure 3 Pooled analysis of p16 hypermethylation in tumorous liver tissues of hepatocellular carcinoma patients and liver tissues of patients with non-tumorous liver diseases. HCC: Hepatocellular carcinoma.
Figure 4
Figure 4 Pooled analysis of p16 hypermethylation in cirrhotic liver tissues and non-cirrhotic liver tissues. HCC: Hepatocellular carcinoma.